Physician profile
Kerry Moose
NPI 1366748931
$1,706.69
in general payments reported to CMS, 2019-2025
12 companies · $144 in 2025
The $144 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $146 · 2022: $187 · 2023: $343 · 2024: $886 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $864 · Long Term Medical Supply Or Device Loan: $509.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $864.12 |
| Long Term Medical Supply Or Device Loan | $508.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $838.56 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Smith+Nephew, INC. | $282.34 | 2021-2024 | Grafix Pl, Stravix Pl, Oasis |
| Polynovo North America LLC | $173.50 | 2024-2025 | Novosorb Btm |
| Organogenesis INC. | $147.49 | 2021-2024 | Puraply |
| Next Science LLC | $112.09 | 2023 | Xperience, Surgx, Blastx |
| Bone Support INC. | $43.91 | 2024 | Cerament G, Ceramentbone Void Filler |
| Tactile Systems Technology INC | $28.68 | 2023-2024 | Entre Plus, Flexitouch Plus |
| Mimedx Group, INC. | $21.91 | 2025 | |
| Melinta Therapeutics, LLC | $15.28 | 2023 | Orbactiv, Kimyrsa |
| Avita Medical Americas, LLC | $14.95 | 2025 | Cohealyx, Permeaderm, Recell |
| Convatec INC. | $14.25 | 2023 | |
| Hydrofera LLC | $13.73 | 2023 | Hydrofera Blue |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kerry Moose listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.